Viridian Therapeutics Inc (VRDN) – Strategy, SWOT and Corporate Finance Report

Viridian Therapeutics Inc (VRDN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Viridian Therapeutics Inc (Viridian), formerly Miragen Therapeutics Inc is a clinical stage biopharmaceutical company. The company discovers and develops novel RNA-based therapeutics, with a core focus on therapeutic antibodies and their roles in diseases. It focuses on thyroid eye disease and cardiovascular disease areas. It’s lead pipeline products candidates include VRDN-001 (Intravenous) for treating thyroid eye disease (TED); and VRDN-002 (Subcutaneous), an inhibitor using half-life technology for treating thyroid eye disease (TED). The company has been depending on the third parties for the manufacturing and supply of the products. Viridian is headquartered in Boulder, Colorado, the US.

Scope

• Detailed information on Viridian Therapeutics Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Viridian Therapeutics Inc in the form of a SWOT analysis

• An in-depth view of the business model of Viridian Therapeutics Inc including a breakdown and examination of key business segments

• News about Viridian Therapeutics Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Viridian Therapeutics Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Viridian Therapeutics Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Viridian Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Horizon Therapeutics Plc

Ionis Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc

Immunovant Inc

Dicerna Pharmaceuticals Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Viridian Therapeutics Inc - Key Facts

Viridian Therapeutics Inc - Key Employees

Viridian Therapeutics Inc - Key Employee Biographies

Viridian Therapeutics Inc - Major Products and Services

Viridian Therapeutics Inc - History

Viridian Therapeutics Inc - Company Statement

Viridian Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Viridian Therapeutics Inc - Business Description

R&D Overview

Viridian Therapeutics Inc - Corporate Strategy

Viridian Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Viridian Therapeutics Inc - Strengths

Viridian Therapeutics Inc - Weaknesses

Viridian Therapeutics Inc - Opportunities

Viridian Therapeutics Inc - Threats

Viridian Therapeutics Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Viridian Therapeutics Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Viridian Therapeutics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 09, 2023: Viridian Therapeutics reports first quarter 2023 financial results and provides corporate update

Mar 01, 2023: Viridian Therapeutics to Webcast Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

Feb 06, 2023: Viridian Appoints Scott Myers as President and Chief Executive Officer

Nov 14, 2022: Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates

Nov 08, 2022: Viridian Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 14, 2022

Aug 15, 2022: Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

Jun 23, 2022: Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer

Apr 06, 2022: Viridian Therapeutics to Participate in The 21st Annual Needham Virtual Healthcare Conference on April 14

Mar 14, 2022: Viridian Therapeutics to Participate in 32nd Annual Oppenheimer Healthcare Conference on March 15

Mar 10, 2022: Viridian Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Updates

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Viridian Therapeutics Inc, Key Facts

Viridian Therapeutics Inc, Key Employees

Viridian Therapeutics Inc, Key Employee Biographies

Viridian Therapeutics Inc, Major Products and Services

Viridian Therapeutics Inc, History

Viridian Therapeutics Inc, Subsidiaries

Viridian Therapeutics Inc, Key Competitors

Viridian Therapeutics Inc, Ratios based on current share price

Viridian Therapeutics Inc, Annual Ratios

Viridian Therapeutics Inc, Annual Ratios (Cont…1)

Viridian Therapeutics Inc, Interim Ratios

Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Viridian Therapeutics Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Viridian Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Viridian Therapeutics Inc, Performance Chart (2018 – 2022)

Viridian Therapeutics Inc, Ratio Charts

Viridian Therapeutics Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Viridian Therapeutics Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports